实证分析-肺结核(4)
抗酸染色阳性，本病人最后患TB可能性为47%，继续维持治疗。
参考文献
1) ACP journal club 1999 march/april Vol130(5) A22
2) Burman WJ 等,A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 1997 Jul;112(1): p63-70
3) Kopelman RI等,Clinical problem-solving. A little math helps the medicine go down.N Engl J Med 1999 Aug 5;341(6): p435-9
, http://www.100md.com
4) Tattevin P等,The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model.Chest 1999 May;115(5): p1248-53
5) Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000 Apr;161(4 Pt 1): p1376-95
, http://www.100md.com
6) Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000 Apr;161(4 Pt 2): pS221-47
, http://www.100md.com
7) Schwartzman K; Menzies D,Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med 2000 Mar;161(3 Pt 1): p780-9
8) Joel G.H, Goodman & Gilman's The pharmacological Basis of Therapeutics McGraw-Hill 9/e pp1155-1163
9) Edgar R.B.等,Diagnostic strategies for common Medical Problems 2/e 1999 ACP-ASIM p354
10) Schlossber G ,Tuberculosis W.B.Saunders company 4/e 1999 p61-62
, 百拇医药
11) Rachard. A. Gross,Making Medical Decisions: An approach to clinical decision making for practicing physicians. 1999 ACP-ASIM
12) Tuberculosis, clinical evidence 2000.3 BMJ p366-373
13) Catanzaro A 等,The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial.JAMA 2000 Feb 2;283(5): p639-45
14) 1990 中华人民共和国卫生部 全国结核病流行病学抽样调查资料汇编 p7
15) Pottumarthy S等,A comparison of seven tests for serological diagnosis of tuberculosis.J Clin Microbiol 2000 Jun;38(6): p2227-31
16) 高孟秋等,不同结核分支杆菌抗原对结核病的诊断价值。中华结核和呼吸杂志 1999/10,22(10)p613-614, 百拇医药(陆慰萱 胡丁君)
参考文献
1) ACP journal club 1999 march/april Vol130(5) A22
2) Burman WJ 等,A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 1997 Jul;112(1): p63-70
3) Kopelman RI等,Clinical problem-solving. A little math helps the medicine go down.N Engl J Med 1999 Aug 5;341(6): p435-9
, http://www.100md.com
4) Tattevin P等,The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model.Chest 1999 May;115(5): p1248-53
5) Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000 Apr;161(4 Pt 1): p1376-95
, http://www.100md.com
6) Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000 Apr;161(4 Pt 2): pS221-47
, http://www.100md.com
7) Schwartzman K; Menzies D,Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med 2000 Mar;161(3 Pt 1): p780-9
8) Joel G.H, Goodman & Gilman's The pharmacological Basis of Therapeutics McGraw-Hill 9/e pp1155-1163
9) Edgar R.B.等,Diagnostic strategies for common Medical Problems 2/e 1999 ACP-ASIM p354
10) Schlossber G ,Tuberculosis W.B.Saunders company 4/e 1999 p61-62
, 百拇医药
11) Rachard. A. Gross,Making Medical Decisions: An approach to clinical decision making for practicing physicians. 1999 ACP-ASIM
12) Tuberculosis, clinical evidence 2000.3 BMJ p366-373
13) Catanzaro A 等,The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial.JAMA 2000 Feb 2;283(5): p639-45
14) 1990 中华人民共和国卫生部 全国结核病流行病学抽样调查资料汇编 p7
15) Pottumarthy S等,A comparison of seven tests for serological diagnosis of tuberculosis.J Clin Microbiol 2000 Jun;38(6): p2227-31
16) 高孟秋等,不同结核分支杆菌抗原对结核病的诊断价值。中华结核和呼吸杂志 1999/10,22(10)p613-614, 百拇医药(陆慰萱 胡丁君)